Everon Biosciences, Inc.

Everon Biosciences, Inc. Extending healthy life. Everon Biosciences, Inc. a private biotechnology company focused on developing novel anti-aging therapeutics.

Aging is a systemic process of progressive dysfunction of tissues and organs associated with chronic inflammation, changes in tissue composition and the quality of cells within the tissues. Everon is a leader in understanding cellular mechanisms of aging and translating this knowledge into development of anti-aging therapies. is headquartered in Buffalo, New York.

Longer life is about efficiency of garbage removal!
06/01/2018

Longer life is about efficiency of garbage removal!

A new study suggests that autophagy, the recycling, and disposal system that cells use to remove unwanted garbage, can extend the healthy lifespan of mamma...

Everon Biosciences hopes to become one of those sparks. Soon!
05/21/2018

Everon Biosciences hopes to become one of those sparks. Soon!

Billionaire Jim Mellon bets that a “stock market mania” will be sparked by technologies that make people live past 100.

What one of the most credible scientists thinks about reversing aging process.
05/07/2018

What one of the most credible scientists thinks about reversing aging process.

Many of you will likely already know who Professor George Church is, and that he is an important and senior member of the research community engaged in tre...

First company developing anti-aging drugs has become public today! Good news for the entire field!
05/03/2018

First company developing anti-aging drugs has become public today! Good news for the entire field!

Unity Biotechnology, a preclinical biotech developing therapies to reduce the effects of aging, raised $85 million by offering 5 million shares at.

A different approach to fight frailty and chronic inflammation in a variety of organs is pursued by Araim Pharmaceutics ...
05/02/2018

A different approach to fight frailty and chronic inflammation in a variety of organs is pursued by Araim Pharmaceutics with a collection of innate repair receptor (IRR) activating peptides.

ARA290 slowed the decline in BHR that accompanied aging (p < 0.03): between 18 and 33 mo BHR decreased from 327 to 276 beats per minute (BPM) in ARA290 and 314 to 261 BPM in the control; between 27 and 33 mo BHR plateaued in ARA290 but continued to decline in the control. IHR declined non-linearly f...

In his lecture at anti-aging conference in Kazan (Russia), Prof. Andrei Gudkov, Everon's CSO, presented evolution of Eve...
04/27/2018

In his lecture at anti-aging conference in Kazan (Russia), Prof. Andrei Gudkov, Everon's CSO, presented evolution of Everon's approach to the development of anti-aging medicines. After his talk he was interviewed by Elena Milova. Here is the text of this interview.

Elena Milova is at the Interventions to extend healthspan and lifespan 2018 conference in Kazan this week. This is an important conference in the aging res...

As far as we know, this is the first and most systematic (at least in its intent) approach for the development of anti-a...
03/04/2018

As far as we know, this is the first and most systematic (at least in its intent) approach for the development of anti-aging therapies. Lots of questions. Which biomarkers will be relevant for measuring short-term positive effects of various treatments? Which therapies will be tested first? When? But this is a welcomed start that should benefit all in anti-aging drug developers community.

We want to help humans live long and healthy lives, and we have built a platform to assess anyones products that can help us achieve that goal.

This is a very promising direction. More and more data shows that genetic instability or DNA damage might be the root ca...
12/04/2017

This is a very promising direction. More and more data shows that genetic instability or DNA damage might be the root cause of aging. SIRT1 is one of the guards that protects DNA. Everon scientists seek novel ways to stabilize DNA pharmacologically.

An anti-aging protein called SIRT1, commonly known for being activated by red wine, has been shown to protect against age-related diseases, such as cancer, neurodegeneration, and cardiovascular disease. A study by researchers at the Gladstone Institutes now reveals that it could also be targeted to?...

Scientifically a very strong investment team. Smart money indeed. Let’s all hope they make the right choices to make us ...
11/25/2017

Scientifically a very strong investment team. Smart money indeed. Let’s all hope they make the right choices to make us forever young.

When British billionaire Jim Mellon wants to map out an investment strategy, he likes to write a book first. Out of that process came his most recent work — Juvenescence: Investing in the Age of Longevity. Now he and some close associates with some of the best connections in biotech

There seems to be an upper limit to human longevity - somewhere around 120 years (122 is the record currently). Learning...
11/25/2017

There seems to be an upper limit to human longevity - somewhere around 120 years (122 is the record currently). Learning how to treat major age-related diseases over last century increased average but did nothing to maximum longevity. Only when we figure out the root cause of disease-independant aging - an aging timer - and learn how to slow this timer down will we increase maximum longevity. Scientists at Everon believe they are on path to accomplishing just that.

While average human life expectancy has increased dramatically in the last century, the maximum lifespan has only modestly increased. These observations prompted the notion that human lifespan might have reached its maximal natural limit of ~115 years. To evaluate this hypothesis, we conducted a sys...

Oisin is one of a handful of companies trying to cure aging by removing senescent cells from the body. The race to find ...
11/19/2017

Oisin is one of a handful of companies trying to cure aging by removing senescent cells from the body. The race to find a cure for aging based on this hypothesis is still on despite growing doubts about the role senescent cells as a root cause of aging.

Oisin Biotechnologies is a rejuvenation biotechnology company which received its seed funding from the Methuselah Foundation and SENS Research Foundation a...

New research that could change our understanding of senescence and how it is related to aging.
11/09/2017

New research that could change our understanding of senescence and how it is related to aging.

Old human cells rejuvenated in breakthrough discovery on aging

Address

640 Ellicott Street
Buffalo, NY
14203

Website

Alerts

Be the first to know and let us send you an email when Everon Biosciences, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category